Furthermore, it has been reported that the accumulation of excess ROS in tumor cells inhibits cancer progression by arresting cancer growth and inducing cell death [84], while CD44-mediated suppression of intracellular ROS has been shown to result in resistance to cancer therapy [85]. Here, CD44 is linked to cancer.